Field Medical raises $14M for next-gen cardiac ablation tech

The FieldForce catheter tip. [Image courtesy of Field Medical]Field Medical announced today that it closed an oversubscribed seed round with investments reaching $14 million.

Private investors led the funding for the Cardiff-by-the-Sea, California-based cardiac ablation technology developer. Multiple strategic investors also joined the round. The company earmarked the funds to support preclinical-to-clinical development activities. That includes first-in-human studies slated to begin in early 2024.

Field Medical was founded last year by Dr. Steven Mickelsen, the founder of Farapulse. Mickelsen also serves as CEO. He led his previous pulsed-field ablation (PFA) technology developer to an acquisition worth at least $460 million by Boston Scientific in 2021. Boston Scientific recently shared positive updates on that Farapulse technology, which Field Medical could eventually look to rival.

The company’s core products, the FieldForce Catheter and FieldForc…

Read more
  • 0

Farapulse founder’s Field Medical partners with CardioNXT on novel pulsed-field ablation tech

Field Medical and CardioNXT announced a strategic collaboration to provide what they say is a first-of-its-kind pulsed-field ablation (PFA) therapy.

The two companies plan to provide a purpose-built PFA therapy integrated with 3D mapping and navigation.

According to a news release, both teams bring decades of experience in pioneering novel PFA and navigation technologies. Their experiences range across various medical applications.

“PFA has generated much excitement in the treatment of atrial fibrillation due to an improved safety profile and procedural workflow. However, most of the first-generation PFA technologies today are repurposed from other applications and suffer from significant limitations outside a subset of AFib procedures,” said Dr. Steven Mickelsen, CEO of Field Medical. “This collaboration brings together second-generation focal PFA and AI-based cardiac mapping—a combination set to revolutionize catheter ablation across …

Read more
  • 0